Steven E Chavoustie Selected Research

secnidazole

1/2021	Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
1/2018	A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven E Chavoustie Research Topics

Disease

3	Bacterial Vaginosis 02/2020 - 04/2015
2	Trichomonas Infections 01/2021 - 01/2020
2	Vaginal Discharge 02/2020 - 01/2018
1	Vulvovaginal Candidiasis 02/2020

Drug/Important Bio-Agent (IBA)

2	secnidazoleIBA 01/2021 - 01/2018
2	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 02/2020 - 04/2015
1	Dendrimers (Dendrons)IBA 02/2020
1	astodrimerIBA 02/2020
1	Nucleic AcidsIBA 01/2020
1	potassium hydroxideIBA 01/2018
1	Metronidazole (Metric)FDA LinkGeneric 04/2015

Therapy/Procedure

1	Treatment Delay 01/2021